Becotatug
Product Specifications
CAS Number
2648260-93-7
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, JAK/STAT signaling, Angiogenesis
Purity
0.991
Bioactivity
Becotatug (JMT101) is a humanised monoclonal antibody targeting EGFR, demonstrating antitumour activity when combined with Osimertinib for treating EGFR-mutated advanced NSCLC.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAC-00928-03 10 mg
[Tyr0] Gastric Inhibitory Peptide (23-42), human
Sign In for Pricing
View Details 